What are safe decongestants for use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

During pregnancy, the safest decongestant options are saline nasal sprays and rinses, as they have no systemic absorption, and pseudoephedrine (Sudafed) can be used after the first trimester in limited doses. When considering medication options, it's essential to weigh the benefits and risks. Pseudoephedrine is generally considered safe after the first trimester, with a recommended dose of 30-60mg every 4-6 hours as needed, not exceeding 240mg daily, and only for short periods 1. Some key points to consider when using decongestants during pregnancy include:

  • Avoiding phenylephrine (PE) due to its limited efficacy and safety data in pregnancy 1
  • Using non-medication approaches such as humidifiers, staying hydrated, elevating the head while sleeping, and trying steam inhalation to help alleviate symptoms
  • Consulting a healthcare provider before taking any medication during pregnancy, as individual health circumstances may affect what's appropriate
  • Being aware that medications that enter the bloodstream can potentially cross the placenta, emphasizing the need for caution and careful consideration of the risks and benefits 1. In terms of specific medication options, chlorpheniramine (an antihistamine with decongestant properties) is also considered safe during pregnancy, although it's crucial to follow the recommended dosage and consult with a healthcare provider 1. Ultimately, the goal is to balance symptom relief with pregnancy safety concerns, and pseudoephedrine, when used judiciously and under medical guidance, can be a viable option for managing congestion during pregnancy.

From the FDA Drug Label

8.1 Pregnancy Risk Summary In animal reproductive and developmental studies, decreased fetal body weights were noted at 0. 4 times the human daily dose (HDD) of 10 mg. No malformations were reported, however, an increased incidence of agenesis of the intermediate lobe of the lung, a visceral variation, was reported at levels as low as 0. 08 times the HDD.

The FDA drug label does not answer the question about safe decongestants for use during pregnancy, as it only provides information about the risks associated with phenylephrine use during pregnancy, but does not provide a list of safe alternatives 2.

From the Research

Safe Decongestants for Use During Pregnancy

  • Pseudoephedrine is one of the most commonly used medications in pregnancy, with an estimated 25% of women exposed 3.
  • Nasal decongestants can be used with caution and up to 7 days during pregnancy 4.
  • The vasoconstrictive effects of decongestants raise the hypothesis that their use in early pregnancy might increase the risk of vascular disruption defects 3.
  • Decongestant use in the first trimester has been associated with small increases in risks of 3 defects thought to arise from vascular disruption: gastroschisis, small intestinal atresia, and hemifacial microsomia 3.

Types of Decongestants

  • Oral decongestants such as phenylpropanolamine, pseudoephedrine, and phenylephrine are commonly used 5.
  • Pseudoephedrine and phenylephrine are considered relatively safe for use during pregnancy, but with caution 3, 4.
  • Phenylpropanolamine has been associated with hemorrhages and cardiovascular and limb malformations in animal models 3.

Precautions and Considerations

  • Decongestant use should be limited to 7 days or less during pregnancy 4.
  • Women with renal impairment should use decongestants with caution 5.
  • The use of decongestants in combination with other medications, such as monoamine oxidase inhibitors, should be avoided 5.
  • The risk of ventricular septal defects was associated with decongestant use in pregnant women in one recent study 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Teratogen update: pseudoephedrine.

Birth defects research. Part A, Clinical and molecular teratology, 2006

Research

Treating common ear problems in pregnancy: what is safe?

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008

Research

Pharmacokinetics of oral decongestants.

Pharmacotherapy, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.